GeneDx launches online exome testing for pediatric patients
Company expands genetic testing access with direct-to-consumer platform for children, aiming to improve diagnostic timelines.
GeneDx, a subsidiary of OPKO Health, has introduced an online exome testing service tailored for pediatric patients. The platform enables parents and guardians to order genetic testing for children directly, without requiring a physician referral in certain jurisdictions.
The service utilizes whole exome sequencing to analyze the protein-coding regions of a child’s genome, identifying potential genetic variants linked to inherited conditions. GeneDx stated the initiative aims to reduce diagnostic delays, which can span years for rare genetic disorders, by providing faster access to genomic insights.
The online platform integrates with existing healthcare workflows, allowing results to be shared with pediatricians or specialists for further evaluation. GeneDx did not disclose pricing details but noted that insurance coverage may vary by plan and region.
The move reflects a broader trend in genetic testing toward direct-to-consumer models, though clinical oversight remains a key component of the service. GeneDx has not provided a timeline for broader rollout beyond the initial launch phase.
Helena covers corporate news for listed and private companies across Europe, from strategy shifts to leadership changes, with an eye for what a story signals about the broader market.
More from Helena Vásquez →
